Encicarb 500 Mg Injection

उत्पाद विवरण

1. Technical Specifications

2. Product Description

Encicarb 500 mg Injection contains Ferric Carboxymaltose, an intravenous iron preparation.
It is used to replenish iron stores in patients with iron deficiency anemia (IDA) when oral iron therapy is ineffective, not tolerated, or contraindicated.
The drug provides a stable ironcarbohydrate complex that allows controlled release of iron to the body, helping in red blood cell production.

3. Product Highlights

4. Therapeutic Uses

• Iron deficiency anemia (IDA): Particularly in patients who cannot tolerate or do not respond to oral iron.

• Chronic Kidney Disease (CKD): Used in both dialysis and non-dialysis patients.

• Post-partum anemia and perioperative anemia.

• Heart failure patients with IDA (as per clinical guidelines in some countries).

5. Side Effects

Common:

• Headache, dizziness

• Nausea, vomiting

• Injection site pain or swelling

• Flushing, taste changes

• Low phosphate levels (hypophosphatemia)

Serious (rare):

• Severe allergic or anaphylactic reaction (shortness of breath, chest pain, hypotension)

• Hypertension during infusion

• Severe skin reactions

• Risk of iron overload if used excessively

6. Precautions

• Administration: Only under medical supervision; resuscitation facilities should be available in case of allergic reactions.

• Renal/Liver Impairment: Caution advised, dose adjustment may be necessary.

• Pregnancy & Breastfeeding: Should be used only if clearly needed and prescribed by the physician.

• Iron Overload: Monitor ferritin and transferrin saturation; avoid in patients with hemochromatosis or iron overload syndromes.

• Drug Interactions: Should not be used concomitantly with oral iron (reduces absorption).